Stocktoria
COGNITION THERAPEUTICS INC CGTX
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-10-08
COGNITION THERAPEUTICS INC financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| R&D expense | $37.2M | $41.7M | $37.2M | $30.3M | $18.6M | $12.9M |
| Operating income | -$47.8M | -$54.0M | -$50.7M | -$43.6M | -$28.6M | -$17.4M |
| Income tax | $0 | $0 | $0 | $0 | $0 | — |
| Net income | -$23.5M | -$34.0M | -$25.8M | -$21.4M | -$11.7M | -$7.8M |
| EPS (diluted) | $-0.32 | $-0.86 | $-0.86 | $-0.91 | $-3.13 | $-23.76 |
| Operating cash flow | -$24.6M | -$28.5M | -$16.0M | -$18.5M | -$3.6M | -$3.4M |
| Free cash flow | — | -$28.5M | -$16.2M | -$18.7M | -$3.7M | -$3.4M |
| Cash & equivalents | $36.8M | $25.0M | $29.9M | $41.6M | $54.7M | $5.2M |
| Total assets | $48.4M | $30.2M | $35.2M | $50.4M | $59.1M | $7.1M |
| Total liabilities | $14.1M | $11.5M | $10.7M | $10.2M | $7.9M | $19.9M |
| Shareholders' equity | $34.3M | $18.8M | $24.5M | $40.2M | $51.3M | -$68.2M |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.